Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

11 Dec 2014 07:00

RNS Number : 4418Z
S & U PLC
11 December 2014
 



11th December 2014

 

S&U PLC ("S&U" or "the company")

 

S&U Trading Statement

 

S&U plc provides a trading update for the period from the 1st August to 10th December 2014.

 

Motor Finance

 

Advantage Finance, our market leading motor finance provider, continues its impressive progress, albeit at a slightly moderated pace of growth in new loan transactions. Debt quality has continued to improve even from last year's record level and year to date, monthly collections are now 40% up on last year. Customer numbers are over a third higher than last year, which, together with record collections and good cost control, promise yet another exemplary profit performance.

 

Home Credit

 

Loansathome4U, our Home Credit business, enters the Christmas peak trading season with debt quality better than for many years and hence credit availability for our customers at record levels. This is reflected in weekly collections ahead by 13% on last year, against a 7% increase in net receivables.

 

The strength of our product offer and the responsibility of our lending is reflected in customer numbers which are up over 7,500 or 9% on 2013. In addition, a 9% rise in representative numbers shows our traditional commitment to high standards of customer care. Management expect that a successful Christmas trading period should confirm the current promising trend in profitability.

 

Following the transfer of consumer credit regulation from the OFT to the FCA on 1st April 2014, preparations for full authorisation due in Q2 2015, continue steadily. Affordability assessments have been revised, reporting lines to the Board reviewed and new Customer Care managers appointed to oversee the process.

 

Funding

 

During the period, a further £15m has been drawndown from our M&G facility to finance growth in both our businesses. Existing facilities provide us with adequate headroom for current requirements and anticipated growth later next year will be funded by additional facilities. Discussions on deposit taking arrangements are ongoing with the regulators and we anticipate making a formal application early in the new financial year.

 

Future Prospects

 

Commenting on Group trading and outlook, Anthony Coombs, S&U Chairman, said:

"Robust growth throughout our businesses is the product of rising consumer confidence, strong debt quality and responsible lending. Our close relationships with our customers and loyal introducer brokers continue to bear fruit in building S&U. We therefore view the future with quiet confidence."

 

 

 

For further information, please contact:

 

S&U plc www.suplc.co.uk

Anthony Coombs, Chairman 0121 705 7777

 

Arden Partners plc

Chris Hardie 020 7614 5917

 

Smithfield

Will Swan 020 7360 4900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRBDDUXBBGSG
Date   Source Headline
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.